IRVING, Texas, May 29, 2009 (GLOBE NEWSWIRE) -- Caris Diagnostics (Caris Dx) - a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology, announced that it has strengthened its hematopathology and oncology franchise with the addition of four experts. Led by Raul C. Braylan, M.D., one of the country’s most respected and prominent hematopathologists as Medical Director of Hematopathology Services, the expanded team provides expert knowledge of molecular technology, diagnostics and flow cytometry for blood and bone marrow cancers.